Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Top Stories

Recent articles that are of ongoing interest...

Cytovant of China Enters $1 Billion Deal for Four Medigene Immunotherapies

C-Bridge Capital and Tasly Invest $150 Million in Two China Biopharmas

Tianjin's CanSino to Raise $160.5 Million for Novel Vaccines in Hong Kong IPO

China Proposes Rules for IPOs on New Shanghai Hi-Tech Stock Exchange

FibroGen/AstraZeneca Novel Anemia Drug Approved in China -- Before US/EU Approvals

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China